The University of Pittsburgh has changed the IRB review fee structure. The fee is required for studies that are industry sponsored. Effective March 1, 2019, the fee schedule will be as follows. There is no charge for modifications.
| Review Process | Project Type | Previous Fee | New Fee |
| Full Board | Initial Review | $2000 | $2500 |
| Continuing Review | $1000 | $1500 | |
| Exempt/Expedited | Initial Review | $1000 | $2000* |
| Expedited | Continuing Review | $500 | $1000 |
*Note: this fee applies only to Expedited. There is no longer an Initial Review fee for Exempt
Studies that are subject to the IRB review fees will not be processed until the fees are paid in full. There may be circumstances when investigators can request a waiver of the fee review and if granted, the fee would not be required. The most common reason for waiver is when the industry collaborator is not funding the entire study but is supporting the study by providing only the drug or other nominal support.
If you have any questions regarding this change, please contact us at askirb@pitt.edu.